Barzin Y Nabet

25PUBLICATIONS
157CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 23, 2026
VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC.

|May 06, 2026
Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity.

|Dec 03, 2025
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.

Tianshi Lu, Habib Hamidi, Mark A Socinski

|Sep 19, 2025
Clonal hematopoiesis is associated with reduced response to atezolizumab in non-small cell lung cancer.

Vylyny Chat, Kipper Fletez-Brant, Minu Srivastava

|Apr 29, 2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer.

Everett J Moding, Mohammad Shahrokh Esfahani, Cheng Jin

|Apr 23, 2025
In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer.

Lauren Brumage, Scott Best, Daniel S Hippe

Pageof 5

Frequent Collaborators

9 joint publications

Ash A Alizadeh

7 joint publications

Maximilian Diehn

6 joint publications

Ira Mellman

6 joint publications

Everett J Moding